Clomiphene Tablets 50mg/tab 50 Tabletten by Genesis

Usage

1. Calculate compound clearance: allow sufficient time after the last injection or oral dose for all suppressive compounds to clear before starting — typically five half-lives of the longest-acting compound in the cycle.
2. Establish your baseline: obtain pre-PCT bloodwork including LH, FSH, total testosterone, and estradiol to confirm the degree of suppression and set a recovery benchmark.
3. Begin the initiation phase: take one 50 mg tablet daily with food during weeks one and two; consistent daily timing (morning preferred) maintains steady receptor occupancy at the hypothalamus.
4. Transition to the taper phase: at the start of week three, split tablets cleanly to administer 25 mg daily; maintain the same daily timing as the initiation phase.
5. Run confirmation bloodwork: at the end of week four, repeat LH, FSH, and total testosterone panels to determine whether hormonal markers have returned to baseline.
6. Decide on extension: if markers confirm baseline recovery, discontinue Clomiphene; if values remain suppressed, continue at 25 mg daily through weeks five and six, then retest before stopping.

Warnings

Frequently asked questions

What does a complete PCT protocol look like after a moderate anabolic cycle?

A standard protocol for moderate suppression typically runs 50 mg clomiphene daily for weeks one and two, followed by 25 mg daily for weeks three and four. If bloodwork at week four shows LH, FSH, or total testosterone still below pre-cycle baseline, an extension at 25 mg through weeks five and six is a commonly applied adjustment. The entire standard course fits within one 50-tablet pack.

What daily clomiphene dose is appropriate for moderate rather than mild suppression?

Most evidence-informed practitioners recommend initiating at 50 mg per day when moderate suppression is present — defined as cycles of eight to fourteen weeks using testosterone esters at 300–600 mg/week or combined oral-injectable stacks. This is higher than the 25 mg starting dose adequate for minimal single-compound runs, because moderate suppression produces a deeper LH/FSH deficit that requires a stronger anti-estrogenic stimulus at the hypothalamic level.

How long does testosterone recovery realistically take after a moderate cycle?

With an active SERM protocol, most users see measurable LH and FSH recovery within two to three weeks, and total testosterone returning toward baseline within four to six weeks. Individual recovery speed depends on pre-cycle hormonal health, compound clearance time, and genetic variability in LH receptor sensitivity. Bloodwork at week four of PCT remains the most reliable way to confirm whether the standard four-week course is sufficient or an extension is warranted.

Can the 50 mg tablet be split to achieve a 25 mg dose during the taper phase?

Yes — Genesis Clomiphene Tablets are compressed with sufficient uniformity to allow accurate splitting into two 25 mg halves for the taper weeks of a moderate-cycle PCT. The HPLC-verified compression consistency of the batch means potency is evenly distributed across the tablet, so a clean half-tablet split delivers a reliably proportional dose without measurement error associated with loose powder or liquid preparations.

Why is 50 mg per tablet a particularly convenient strength for a graded PCT protocol?

The 50 mg unit dose eliminates the need for dose calculation during the initiation phase — one tablet equals the full recommended daily dose for weeks one and two of a moderate-cycle protocol. For the taper phase, a single tablet split cleanly yields the 25 mg dose, so one pack format covers both protocol phases without requiring a separate lower-strength product. This single-strength versatility makes the Genesis 50 mg tablet operationally simpler than sourcing two different tablet strengths. (2) angle_used

Manufacturer

Genesis applies a release-gate architecture to its Clomiphene Citrate 50 mg tablet line that treats finished-batch analytical sign-off as a mandatory production checkpoint rather than a post-market quality review. The active pharmaceutical ingredient — clomiphene citrate — is assessed at incoming receipt for identity and purity, with HPLC quantification against a certified reference standard establishing the per-gram potency of the raw material before it enters tablet compression. A second HPLC measurement is conducted on finished tablets drawn from the released batch, confirming that the compression and excipient-blending process has not altered declared per-tablet content. Endotoxin burden is evaluated using the LAL (Limulus Amebocyte Lysate) method — a bacterial endotoxin test standard that Genesis applies across its oral solid-dosage portfolio in recognition that pyrogenic contamination risk is not exclusive to parenteral forms. Production occurs within GMP-compliant facilities operating under ISO-classified environmental controls, with temperature and humidity parameters monitored continuously through the compression, coating, and packaging stages. This quality framework is particularly relevant for a SERM used in moderate-cycle recovery contexts, where per-tablet dose accuracy directly determines the adequacy of gonadotropin stimulation during the protocol's critical initiation weeks.